Found 19 bookmarks
Newest
🔥📣 I am thrilled to bring you this fascinating, shocking interview with former CDC Director, Dr. Robert Redfield. 👀 I almost fell off my seat a number of times. 👀
🔥📣 I am thrilled to bring you this fascinating, shocking interview with former CDC Director, Dr. Robert Redfield. 👀 I almost fell off my seat a number of times. 👀
“🔥📣 I am thrilled to bring you this fascinating, shocking interview with former CDC Director, Dr. Robert Redfield. 👀 I almost fell off my seat a number of times. 👀”
·x.com·
🔥📣 I am thrilled to bring you this fascinating, shocking interview with former CDC Director, Dr. Robert Redfield. 👀 I almost fell off my seat a number of times. 👀
A protein vaccine of RBD integrated with immune evasion mutation shows broad protection against SARS-CoV-2
A protein vaccine of RBD integrated with immune evasion mutation shows broad protection against SARS-CoV-2

A protein-based vaccine against SARS-CoV-2 has been developed.

It is based on the spike protein containing a modified receptor binding domain (cRBD) with a set of engineered mutations.

It provides broad protection against various SARS-CoV-2 variants.

·nature.com·
A protein vaccine of RBD integrated with immune evasion mutation shows broad protection against SARS-CoV-2
Antigenic imprinting dominates humoral responses to new variants of SARS-CoV-2 in a hamster model of COVID-19
Antigenic imprinting dominates humoral responses to new variants of SARS-CoV-2 in a hamster model of COVID-19

Study at KU Leuven on hamsters finds that immunity from XBB.1.5 COVID-19 vaccine favors the original strain, limiting antibody response to newer variants like JN.1.

Highlights the challenge of updating vaccines for evolving SARS-CoV-2.

·biorxiv.org·
Antigenic imprinting dominates humoral responses to new variants of SARS-CoV-2 in a hamster model of COVID-19
Why protective antibodies fade after COVID-19 vaccines
Why protective antibodies fade after COVID-19 vaccines

While effective at preventing severe COVID-19, the protection you get from mRNA vaccines can fade within months.

Long-lasting immune cells that fight SARS-CoV-2 aren't usually found in mRNA-vaccinated people, unlike the immune cells for tetanus and flu.

·nih.gov·
Why protective antibodies fade after COVID-19 vaccines
Is this the way COVID ends? Next-generation inhaled vaccines could be the key to ending pandemic
Is this the way COVID ends? Next-generation inhaled vaccines could be the key to ending pandemic

“Is this the way COVID ends? Next-generation inhaled vaccines could be the key to ending pandemic Existing COVID-19 vaccines can prevent severe disease, but not infection. A new hope comes in the form of needle-free mucosal vaccines…

…Some see mucosal vaccines as the best hope to end the COVID-19 pandemic. They are now in development in labs around the world, including in Canada. The United States and other countries are investing heavily in the development of mucosal vaccines for COVID-19 and beyond.”

Is this the way COVID ends? Next-generation inhaled vaccines could be the key to ending pandemicExisting COVID-19 vaccines can prevent severe disease, but not infection. A new hope comes in the form of needle-free mucosal vaccines.
·ottawacitizen.com·
Is this the way COVID ends? Next-generation inhaled vaccines could be the key to ending pandemic
An important study by F. Eun-Hyung Lee's team shows that long lived plasma cells (the source of long-term circulating antibodies) fail to establish after mRNA vaccination (even combined with SARS-CoV-2 infection). 🧵 (1/)
An important study by F. Eun-Hyung Lee's team shows that long lived plasma cells (the source of long-term circulating antibodies) fail to establish after mRNA vaccination (even combined with SARS-CoV-2 infection). 🧵 (1/)
“In summary, this study shows that for some reason, vaccination against Spike with mRNA vaccine (even combined with infection) fails to establish long lived plasma cells that provide IgG against the virus long term.”
·x.com·
An important study by F. Eun-Hyung Lee's team shows that long lived plasma cells (the source of long-term circulating antibodies) fail to establish after mRNA vaccination (even combined with SARS-CoV-2 infection). 🧵 (1/)
COVID shots no longer free for uninsured, could cost up to $200
COVID shots no longer free for uninsured, could cost up to $200
The federal bridge access program was set to end this December, but it expired early because of a move by Congress.
The federal bridge access program was set to end this December, but it expired early because of a move by Congress.
·abc7.com·
COVID shots no longer free for uninsured, could cost up to $200
Study puts understanding of long COVID and vaccination into question | CIDRAP
Study puts understanding of long COVID and vaccination into question | CIDRAP

“A new study from researchers at the Mayo Clinic suggests that being vaccinated against COVID-19 does little to prevent long COVID.

The findings contradict what has become conventional wisdom in the last 3 years—that vaccines offer a chance to significantly reduce the risk of long COVID, or new or persistent symptoms 3 months or more after infection, most likely by reducing the severity of infection.

Melanie Swift, MD, MPH, was the lead author of the study, which was published in Open Forum Infectious Diseases. She said despite the current thinking that vaccines reduce the risk of developing long COVID, she wasn’t surprised she found no association.”

·cidrap.umn.edu·
Study puts understanding of long COVID and vaccination into question | CIDRAP
Scientists Develop Game-Changing Needle-Free COVID-19 Intranasal Vaccine
Scientists Develop Game-Changing Needle-Free COVID-19 Intranasal Vaccine
“The vaccine induces strong memory responses in the nasal mucosa offering long-term protection for up to a year or more. It’s been designed to be administered as a single dose, ideally as a booster vaccine, as a safe alternative to needles with no adverse reactions in the short or long term.”
·scitechdaily.com·
Scientists Develop Game-Changing Needle-Free COVID-19 Intranasal Vaccine
New vector vaccine against COVID-19 provides long-term protection
New vector vaccine against COVID-19 provides long-term protection

So naturally we will never get it.

unlike limited and quickly waning efficacy of MRNA, “innovative vector vaccine developed at the Helmholtz Center for Infection Research (HZI) presents a compelling alternative. It elicits prolonged immune response in animal models, and maintains its efficacy over extended time.”

·medicalxpress.com·
New vector vaccine against COVID-19 provides long-term protection
COVID-19 vaccinations to resume amid surge in cases
COVID-19 vaccinations to resume amid surge in cases

August, 2024: South Korea: COVID-19 vaccinations to resume amid surge in cases

"Just 4 months after fully shifting to endemic approach, gov’t scrambles to contain virus."

The Korea Times

·m.koreatimes.co.kr·
COVID-19 vaccinations to resume amid surge in cases
A Huge Boost for Mucosal Covid Vax Development (Next Generation Update 15) - Absolutely Maybe
A Huge Boost for Mucosal Covid Vax Development (Next Generation Update 15) - Absolutely Maybe

“Mucosal vaccines go directly into the mucosal tissue where infection begins – for example, intranasally or via tablets. If they could induce strong enough mucosal immunity, such vaccines could reduce the risk of infection and transmission. That’s often called “sterilizing” immunity.

Development of these vaccines has just received a massive boost. A global consortium is being funded to develop and then run human challenge trials of intranasal or inhaled vaccines in a program called MusiCC.”

·absolutelymaybe.plos.org·
A Huge Boost for Mucosal Covid Vax Development (Next Generation Update 15) - Absolutely Maybe